Cap-independent translation of human SP-A 5′-UTR variants: A double-loop structure and cis-element contribution

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 296, Issue 4, 2009, Pages

  Wang, Guirong ^a   Guo, Xiaoxuan ^a   Silveyra, Patricia ^a   Kimball, Scot R ^a   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

5 untranslated region; Circular RNA; Diesel particulate matter; H441 cells; Internal ribosome entry site; Secondary structure of mRNA; Surfactant protein A

Indexed keywords

ADENOSINE; FIREFLY LUCIFERASE; OZONE; SURFACTANT PROTEIN A; CAPPED RNA;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; ENERGY; EXHAUST GAS; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RENILLA; REPORTER GENE; RNA TRANSLATION; TRANSIENT TRANSFECTION; ALTERNATIVE RNA SPLICING; CONFORMATION; DRUG EFFECT; GENE DELETION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; REGULATORY SEQUENCE; TUMOR CELL LINE;

5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; OZONE; PARTICULATE MATTER; PROTEIN BIOSYNTHESIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; REGULATORY SEQUENCES, NUCLEIC ACID; RNA CAPS; SEQUENCE DELETION;

EID: 65549164051     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90508.2008     Document Type: Article

References (82)

1. Akiri G, Nahari D, Finkelstein Y, Le SY, Elroy-Stein O, Levi BZ. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17: 227-236, 1998. (Pubitemid 28371896)
2. Baird SD, Lewis SM, Turcotte M, Holcik M. A search for structurally similar cellular internal ribosome entry sites. Nucleic Acids Res 35: 4664-4677, 2007. (Pubitemid 47250339)
3. Baird SD, Turcotte M, Korneluk RG, Holcik M. Searching for IRES. RNA 12: 1755-1785, 2006. (Pubitemid 44484249)
4. Bert AG, Grepin R, Vadas MA, Goodall GJ. Assessing IRES activity in the HIF-1alpha and other cellular 5′ UTRs. RNA 12: 1074-1083, 2006. (Pubitemid 43788125)
5. Bonnal S, Schaeffer C, Creancier L, Clamens S, Moine H, Prats AC, Vagner S. A single internal ribosome entry site containing a G quartet RNA structure drives fibroblast growth factor 2 gene expression at four alternative translation initiation codons. J Biol Chem 278: 39330-39336, 2003. (Pubitemid 37248488)
6. Carter PS, Jarquin-Pardo M, De Benedetti A. Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5′UTR. Oncogene 18: 4326-4335, 1999. (Pubitemid 29392373)
7. Cencig S, Nanbru C, Le SY, Gueydan C, Huez G, Kruys V. Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5′ untranslated region. Oncogene 23: 267-277, 2004. (Pubitemid 38142261)
8. Chen CY, Sarnow P. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science 268: 415-417, 1995.
9. Cormier Y, Israel-Assayag E, Desmeules M, Lesur O. Effect of contact avoidance or treatment with oral prednisolone on bronchoalveolar lavage surfactant protein A levels in subjects with farmer's lung. Thorax 51: 1210-1215, 1996. (Pubitemid 26413139)
10. de Breyne S, Yu Y, Pestova TV, Hellen CU. Factor requirements for translation initiation on the simian picornavirus internal ribosomal entry site. RNA 14: 367-380, 2008.
11. De Rijk P, Wuyts J, De Wachter R. RnaViz 2: an improved representation of RNA secondary structure. Bioinformatics 19: 299-300, 2003. (Pubitemid 36181922)
12. Dowell RD, Eddy SR. Evaluation of several lightweight stochastic context-free grammars for RNA secondary structure prediction. BMC Bioinformatics 5: 71, 2004.
13. Floros J, Phelps DS. Pulmonary surfactant. In: Anesthesia: Biologic Foundations, edited by Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, Saidman LJ. Philadelphia, PA: Lippincott-Raven, 1997, p. 1259-1279.
14. Garcia-Verdugo I, Wang G, Floros J, Casals C. Structural analysis and lipid-binding properties of recombinant human surfactant protein A derived from one or both genes. Biochemistry 41: 14041-14053, 2002. (Pubitemid 35364877)
15. George CL, White ML, O'Neill ME, Thorne PS, Schwartz DA, Snyder JM. Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 285: L1337-L1344, 2003.
16. Gilbert WV, Zhou K, Butler TK, Doudna JA. Cap-independent translation is required for starvation-induced differentiation in yeast. Science 317: 1224-1227, 2007.
17. Gray NK, Wickens M. Control of translation initiation in animals. Annu Rev Cell Dev Biol 14: 399-458, 1998. (Pubitemid 29001460)
18. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160: 1843-1850, 1999. (Pubitemid 30004685)
19. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996. (Pubitemid 26026846)
20. Guzman J, Wang YM, Kalaycioglu O, Schoenfeld B, Hamm H, Bartsch W, Costabel U. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis. Acta Cytol 36: 668-673, 1992.
21. Hamm H, Luhrs J, Guzman y Rotaeche J, Costabel U, Fabel H, Bartsch W. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 106: 1766-1770, 1994.
22. Haque R, Umstead TM, Ponnuru P, Guo X, Hawgood S, Phelps DS, Floros J. Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice. Toxicol Appl Pharmacol 220: 72-82, 2007. (Pubitemid 46427858)
23. Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15: 1593-1612, 2001. (Pubitemid 32702581)
24. Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol 1: 190-192, 1999. (Pubitemid 129656025)
25. Holcik M, Pestova TV. Translation mechanism and regulation: old players, new concepts. Meeting on translational control and non-coding RNA. EMBO Rep 8: 639-643, 2007. (Pubitemid 47029470)
26. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318-327, 2005. (Pubitemid 40516898)
27. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 18: 353-362, 1998. (Pubitemid 128354093)
28. Huang W, Wang G, Phelps DS, Al-Mondhiry H, Floros J. Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation. Am J Physiol Lung Cell Mol Physiol 286: L546-L553, 2004. (Pubitemid 38233626)
29. Huez I, Creancier L, Audigier S, Gensac MC, Prats AC, Prats H. Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol Cell Biol 18: 6178-6190, 1998. (Pubitemid 28500509)
30. Jackson RJ. Alternative mechanisms of initiating translation of mammalian mRNAs. Biochem Soc Trans 33: 1231-1241, 2005.
31. Jang GM, Leong LE, Hoang LT, Wang PH, Gutman GA, Semler BL. Structurally distinct elements mediate internal ribosome entry within the 5′-noncoding region of a voltage-gated potassium channel mRNA. J Biol Chem 279: 47419-47430, 2004.
32. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62: 2636-2643, 1988. (Pubitemid 18193855)
33. Karinch AM, Floros J. 5′ Splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 12: 77-88, 1995.
34. Karinch AM, Floros J. Translation in vivo of 5′ untranslated-region splice variants of human surfactant protein-A. Biochem J 307: 327-330, 1995.
35. Komar AA, Hatzoglou M. Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J Biol Chem 280: 23425-23428, 2005. (Pubitemid 40884816)
36. Kumar AR, Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol Lung Cell Mol Physiol 274: L177-L185, 1998.
37. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 13: 1792-1801, 2002. (Pubitemid 34522656)
38. Le Quesne JP, Stoneley M, Fraser GA, Willis AE. Derivation of a structural model for the c-myc IRES. J Mol Biol 310: 111-126, 2001. (Pubitemid 32619956)
39. Le SY, Maizel JV Jr. A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucleic Acids Res 25: 362-369, 1997.
40. Lesur O, Bernard AM, Begin RO. Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers. Chest 109: 467-474, 1996. (Pubitemid 26058607)
41. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 158: 4336-4340, 1997.
42. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103: 1015-1021, 1999. (Pubitemid 29169609)
43. LeVine AM, Hartshorn K, Elliott J, Whitsett J, Korfhagen T. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 282: L563-L572, 2002. (Pubitemid 34654662)
44. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19: 700-708, 1998.
45. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20: 279-286, 1999.
46. Macejak DG, Sarnow P. Internal initiation of translation mediated by the 5′ leader of a cellular mRNA. Nature 353: 90-94, 1991. (Pubitemid 21912465)
47. Madsen J, Tornoe I, Nielsen O, Koch C, Steinhilber W, Holmskov U. Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol 29: 591-597, 2003. (Pubitemid 37357710)
48. McCormack FX, King TE Jr, Bucher BL, Nielsen L, Mason RJ, McCormac FX. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152: 751-759, 1995.
49. McCormack FX, King TE Jr, Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 144: 160-166, 1991.
50. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109: 707-712, 2002.
51. McCormick SM, Boggaram V, Mendelson CR. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 266: L354-L366, 1994. (Pubitemid 2081544)
52. McCormick SM, Mendelson CR. Human SP-A1 and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids. Am J Physiol Lung Cell Mol Physiol 266: L367-L374, 1994.
53. Mikerov AN, Umstead TM, Gan X, Huang W, Guo X, Wang G, Phelps DS, Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol 294: L121-L130, 2008.
54. Mikerov AN, Umstead TM, Huang W, Liu W, Phelps DS, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 288: L150-L158, 2005. (Pubitemid 40023897)
55. Mikerov AN, Wang G, Umstead TM, Zacharatos M, Thomas NJ, Phelps DS, Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun 75: 1403-1412, 2007. (Pubitemid 46385834)
56. Mitchell SA, Spriggs KA, Coldwell MJ, Jackson RJ, Willis AE. The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell 11: 757-771, 2003.
57. Mokrejs M, Vopalensky V, Kolenaty O, Masek T, Feketova Z, Sekyrova P, Skaloudova B, Kriz V, Pospisek M. IRESite: the database of experimentally verified IRES structures (www.iresite.org). Nucleic Acids Res 34: D125-D130, 2006.
58. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334: 320-325, 1988. (Pubitemid 18177659)
59. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 20: 269-292, 2001.
60. Phelps DS, Floros J. Localization of surfactant protein synthesis in human lung by in situ hybridization. Am Rev Respir Dis 137: 939-942, 1988. (Pubitemid 18099312)
61. Phelps DS, Umstead TM, Mejia M, Carrillo G, Pardo A, Selman M. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis. Chest 125: 617-625, 2004. (Pubitemid 38223644)
62. Pisarev AV, Chard LS, Kaku Y, Johns HL, Shatsky IN, Belsham GJ. Functional and structural similarities between the internal ribosome entry sites of hepatitis C virus and porcine teschovirus, a picornavirus. J Virol 78: 4487-4497, 2004. (Pubitemid 38501068)
63. Quintero OA, Korfhagen TR, Wright JR. Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Physiol 283: L76-L85, 2002.
64. Rubtsova MP, Sizova DV, Dmitriev SE, Ivanov DS, Prassolov VS, Shatsky IN. Distinctive properties of the 5′-untranslated region of human hsp70 mRNA. J Biol Chem 278: 22350-22356, 2003.
65. Sella O, Gerlitz G, Le SY, Elroy-Stein O. Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein. Mol Cell Biol 19: 5429-5440, 1999. (Pubitemid 29339901)
66. Sonenberg N, Dever T. Eukaryotic translation initiation factors and regulators. Curr Opin Struct Biol 13: 56-63, 2003. (Pubitemid 36170255)
67. Stoneley M, Chappell SA, Jopling CL, Dickens M, MacFarlane M, Willis AE. c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol Cell Biol 20: 1162-1169, 2000. (Pubitemid 30069236)
68. Su WY, Gordon T. Alterations in surfactant protein A after acute exposure to ozone. J Appl Physiol 80: 1560-1567, 1996. (Pubitemid 26143904)
69. Sugahara K, Iyama K, Sano K, Kuroki Y, Akino T, Matsumoto M. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury. Lab Invest 74: 209-220, 1996. (Pubitemid 26041023)
70. Tagaram HR, Wang G, Umstead TM, Mikerov AN, Thomas NJ, Graff GR, Hess JC, Thomassen MJ, Kavuru MS, Phelps DS, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol 292: L1052-L1063, 2007. (Pubitemid 47084850)
71. Voss T, Melchers K, Scheirle G, Schafer KP. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. Am J Respir Cell Mol Biol 4: 88-94, 1991.
72. Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 43: 4227-4239, 2004. (Pubitemid 38445644)
73. Wang G, Guo X, Floros J. Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: L497-L508, 2005. (Pubitemid 41192726)
74. Wang G, Myers C, Mikerov A, Floros J. Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants. Biochemistry 46: 8425-8435, 2007. (Pubitemid 47075979)
75. Wang G, Phelps DS, Umstead TM, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 278: L946-L954, 2000. (Pubitemid 30351049)
76. Wang G, Taneva S, Keough KM, Floros J. Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B. Biochim Biophys Acta 1768: 2060-2069, 2007. (Pubitemid 47385888)
77. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 110: 79-84, 2002. (Pubitemid 34110705)
78. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68, 2005.
79. Young RM, Wang SJ, Gordan JD, Ji X, Liebhaber SA, Simon MC. Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J Biol Chem 283: 16309-16319, 2008.
80. Zuker M. Calculating nucleic acid secondary structure. Curr Opin Struct Biol 10: 303-310, 2000. (Pubitemid 30333099)
81. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415, 2003. (Pubitemid 37442169)
82. Zuker M, Jacobson AB. Using reliability information to annotate RNA secondary structures. RNA 4: 669-679, 1998. (Pubitemid 28252749)